This group is for men with complex disease either at diagnosis, or whose disease has recurred with or without evidence of metastasis. With men who have experienced the gamut of treatments, we discuss status, as well as new developments in treatment and technology. New participants are given priority to discuss their situation.
1st & 3rd Mondays of every month at 8pm EST/EDT (US)
2nd & 4th Tuesdays of every month at 6pm EST/EDT (US)
NB October 2019 Tuesday meetings moved to 3rd & 5th Tuesday due to calendar anomaly.
Side effects and remedies from Neulasta during chemo; non-palliative spot radiation for oligo-Mx; more on Neurontin; ProstVac fails; Neuroticism impacts treatment results; Language of Cancer; return of testosterone after stopping LHRH on IHT; how second line anti-androgens function
Rick Davis, AnCan’s Founder, was honored to be one of Janssen’s guest asked to walk the runway at the 3rd Annual PCF Blue Jacket Gala held at Chelsea Piers, NYV on Feb 7, 2019. Dressd by Mens Wearhouse, Rick walked in memory of our dear co-founder, Rob Barniskis, who was not well enough to walk the runway last year. Rick also remembered Dan Zenka, the former PCF VP of Communications.
Want to show & tell …. please send news and/or pix to info@Ancan.org.
Broad Institute record requests; inter institution tissue slide requests; old vs new samples for testing; liquid vs solid tumor tests; FDA’s pan-cancer approvals; what does precision medicine mean?; continued success with Zytiga; S.A.M. pro’s & con’s; muscle cramp solutions; how much upfront ADT for Gleason 9?; treating recurrent disease. Check the new keyword, transcript function
Eric Buchbinder GRHS; aggressive, low PSA, advanced PCa; post-RP recovery; pros & cons of SpaceOar; find a QB doc after clinical trial; don’t forget your bone density test; spot/salvage PBRT experiences; BAT – bipolar androgen therapy; vitamins and supplements Check the new keyword, transcript function
